Abstract
The COVID-19 pandemic has potentially increased the risk for adolescent depression. Even pre-pandemic, <50% of youth with depression accessed care, highlighting needs for accessible interventions. Accordingly, this randomized-controlled trial (ClinicalTrials.gov: NCT04634903) tested online single-session interventions (SSIs) during COVID-19 in adolescents with elevated depression symptoms (N=2,452, ages 13-16). Adolescents from all 50 U.S. states, recruited via social media, were randomized to 1 of 3 SSIs: a behavioural activation SSI, an SSI teaching that traits are malleable, or a supportive control. We tested each SSI’s effects on post-intervention (hopelessness, agency) and 3-month outcomes (depression, hopelessness, agency, generalized anxiety, COVID-related trauma, restrictive eating). Versus control, both active SSIs reduced 3-month depressive symptoms (ds=0.18); decreased post-intervention and 3-month hopelessness (ds=0.16-0.28); increased post-intervention agency (ds=0.15-0.31); and reduced 3-month restrictive eating (ds=0.12-17). Several differences between active SSIs emerged. Results confirm the utility of free-of-charge, online SSIs for high-symptom adolescents, even in the high-stress COVID-19 context.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
